You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global and China Pharmaceutical Sterility Testing Market Size, Status and Forecast 2020-2026

Sterility testing is an important part of GMP microbiology, and is used to ensure that pharmaceutical and biopharmaceutical therapeutics are sterile and safe for human use.
Government investments in the healthcare industry, increasing RandD activities and number of drug launches, and rising focus on quality and sterility are projected to drive the market. According to UNESCO report, U.S., China, Japan, and Germany were among the top five nations in terms of RandD expenditure in 2016.
Market Analysis and Insights: Global Pharmaceutical Sterility Testing Market
The global Pharmaceutical Sterility Testing market size is projected to reach US$ 1266.8 million by 2026, from US$ 858.9 million in 2020, at a CAGR of 6.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutical Sterility Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutical Sterility Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutical Sterility Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutical Sterility Testing market.
Pharmaceutical Sterility Testing Breakdown Data by Type
Sterility Testing
Bioburden Testing
Bacterial Endotoxin Testing
Pharmaceutical Sterility Testing Breakdown Data by Application
Compounding Pharmacies
Medical Devices Companies
Pharmaceutical Companies
Others
Based on regional and country-level analysis, the Pharmaceutical Sterility Testing market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Pharmaceutical Sterility Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
SGS SA
Toxikon, Inc.
Pace Analytical Services, LLC
Boston Analytical
Charles River Laboratories International, Inc.
Nelson Laboratories.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Sterility Testing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Sterility Testing
1.2.3 Bioburden Testing
1.2.4 Bacterial Endotoxin Testing
1.3 Market by Application
1.3.1 Global Pharmaceutical Sterility Testing Market Share by Application: 2020 VS 2026
1.3.2 Compounding Pharmacies
1.3.3 Medical Devices Companies
1.3.4 Pharmaceutical Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pharmaceutical Sterility Testing Market Perspective (2015-2026)
2.2 Global Pharmaceutical Sterility Testing Growth Trends by Regions
2.2.1 Pharmaceutical Sterility Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmaceutical Sterility Testing Historic Market Share by Regions (2015-2020)
2.2.3 Pharmaceutical Sterility Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Sterility Testing Players by Market Size
3.1.1 Global Top Pharmaceutical Sterility Testing Players by Revenue (2015-2020)
3.1.2 Global Pharmaceutical Sterility Testing Revenue Market Share by Players (2015-2020)
3.2 Global Pharmaceutical Sterility Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Sterility Testing Revenue
3.4 Global Pharmaceutical Sterility Testing Market Concentration Ratio
3.4.1 Global Pharmaceutical Sterility Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Sterility Testing Revenue in 2019
3.5 Key Players Pharmaceutical Sterility Testing Area Served
3.6 Key Players Pharmaceutical Sterility Testing Product Solution and Service
3.7 Date of Enter into Pharmaceutical Sterility Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Sterility Testing Breakdown Data by Type (2015-2026)
4.1 Global Pharmaceutical Sterility Testing Historic Market Size by Type (2015-2020)
4.2 Global Pharmaceutical Sterility Testing Forecasted Market Size by Type (2021-2026)

5 Pharmaceutical Sterility Testing Breakdown Data by Application (2015-2026)
5.1 Global Pharmaceutical Sterility Testing Historic Market Size by Application (2015-2020)
5.2 Global Pharmaceutical Sterility Testing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Pharmaceutical Sterility Testing Market Size (2015-2026)
6.2 North America Pharmaceutical Sterility Testing Market Size by Type (2015-2020)
6.3 North America Pharmaceutical Sterility Testing Market Size by Application (2015-2020)
6.4 North America Pharmaceutical Sterility Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Pharmaceutical Sterility Testing Market Size (2015-2026)
7.2 Europe Pharmaceutical Sterility Testing Market Size by Type (2015-2020)
7.3 Europe Pharmaceutical Sterility Testing Market Size by Application (2015-2020)
7.4 Europe Pharmaceutical Sterility Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Pharmaceutical Sterility Testing Market Size (2015-2026)
8.2 China Pharmaceutical Sterility Testing Market Size by Type (2015-2020)
8.3 China Pharmaceutical Sterility Testing Market Size by Application (2015-2020)
8.4 China Pharmaceutical Sterility Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Pharmaceutical Sterility Testing Market Size (2015-2026)
9.2 Japan Pharmaceutical Sterility Testing Market Size by Type (2015-2020)
9.3 Japan Pharmaceutical Sterility Testing Market Size by Application (2015-2020)
9.4 Japan Pharmaceutical Sterility Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Pharmaceutical Sterility Testing Market Size (2015-2026)
10.2 Southeast Asia Pharmaceutical Sterility Testing Market Size by Type (2015-2020)
10.3 Southeast Asia Pharmaceutical Sterility Testing Market Size by Application (2015-2020)
10.4 Southeast Asia Pharmaceutical Sterility Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
11.1 SGS SA
11.1.1 SGS SA Company Details
11.1.2 SGS SA Business Overview
11.1.3 SGS SA Pharmaceutical Sterility Testing Introduction
11.1.4 SGS SA Revenue in Pharmaceutical Sterility Testing Business (2015-2020))
11.1.5 SGS SA Recent Development
11.2 Toxikon, Inc.
11.2.1 Toxikon, Inc. Company Details
11.2.2 Toxikon, Inc. Business Overview
11.2.3 Toxikon, Inc. Pharmaceutical Sterility Testing Introduction
11.2.4 Toxikon, Inc. Revenue in Pharmaceutical Sterility Testing Business (2015-2020)
11.2.5 Toxikon, Inc. Recent Development
11.3 Pace Analytical Services, LLC
11.3.1 Pace Analytical Services, LLC Company Details
11.3.2 Pace Analytical Services, LLC Business Overview
11.3.3 Pace Analytical Services, LLC Pharmaceutical Sterility Testing Introduction
11.3.4 Pace Analytical Services, LLC Revenue in Pharmaceutical Sterility Testing Business (2015-2020)
11.3.5 Pace Analytical Services, LLC Recent Development
11.4 Boston Analytical
11.4.1 Boston Analytical Company Details
11.4.2 Boston Analytical Business Overview
11.4.3 Boston Analytical Pharmaceutical Sterility Testing Introduction
11.4.4 Boston Analytical Revenue in Pharmaceutical Sterility Testing Business (2015-2020)
11.4.5 Boston Analytical Recent Development
11.5 Charles River Laboratories International, Inc.
11.5.1 Charles River Laboratories International, Inc. Company Details
11.5.2 Charles River Laboratories International, Inc. Business Overview
11.5.3 Charles River Laboratories International, Inc. Pharmaceutical Sterility Testing Introduction
11.5.4 Charles River Laboratories International, Inc. Revenue in Pharmaceutical Sterility Testing Business (2015-2020)
11.5.5 Charles River Laboratories International, Inc. Recent Development
11.6 Nelson Laboratories.
11.6.1 Nelson Laboratories. Company Details
11.6.2 Nelson Laboratories. Business Overview
11.6.3 Nelson Laboratories. Pharmaceutical Sterility Testing Introduction
11.6.4 Nelson Laboratories. Revenue in Pharmaceutical Sterility Testing Business (2015-2020)
11.6.5 Nelson Laboratories. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Aug, 2020
  • NO OF PAGES: 128